Therapix Biosciences (Israel) Alpha and Beta Analysis Overview

TRPX -- Israel Stock  

null 33.70  0.70  2.12%

This module allows you to check different measures of market premium for Therapix Biosciences Ltd as well as systematic risk associated with investing in Therapix Biosciences over a specified time horizon. Also please take a look at World Market Map.
Horizon     30 Days    Login   to change
Run Premiums

Therapix Biosciences Market Premiums

α0.00   β0.00
30 days against DJI

Therapix Biosciences Fundamentals

 Better Than Average     
 Worse Than Average Compare Therapix Biosciences to competition

Therapix Biosciences Fundamental Vs Peers

FundamentalsTherapix BiosciencesPeer Average
Return On Equity(216.64)% (15.17)%
Return On Asset(37.65)% (15.64)%
Current Valuation58.23M152.14B
Shares Outstanding139.89M1.43B
Net Income(7.66M)517.71M
Cash and Equivalents7.51M3.89B

Therapix Biosciences Opportunities

Therapix Biosciences Return and Market Media

The median price of Therapix Biosciences for the period between Wed, Oct 17, 2018 and Sun, Dec 16, 2018 is 31.4 with a coefficient of variation of 58.97. The daily time series for the period is distributed with a sample standard deviation of 14.56, arithmetic mean of 24.69, and mean deviation of 12.34. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  

Current Sentiment - TRPX

Therapix Biosciences Investor Sentiment

Macroaxis portfolio users are evenly split in their outlook on investing in Therapix Biosciences Ltd. What is your outlook on investing in Therapix Biosciences Ltd? Are you bullish or bearish?
50% Bullish
50% Bearish

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Also please take a look at World Market Map. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.